Bluebird Pretax Profit Margin from 2010 to 2024
| BLUE Stock | USD 0.92 0.01 1.10% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter (85.19) | Current Value (80.93) | Quarterly Volatility 43.99350794 |
Check Bluebird Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluebird main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.2 M, Selling General Administrative of 125.4 M or Total Revenue of 40.7 M, as well as many exotic indicators such as Price To Sales Ratio of 243, Dividend Yield of 0.0 or PTB Ratio of 2.62. Bluebird financial statements analysis is a perfect complement when working with Bluebird Bio Valuation or Volatility modules.
Bluebird | Pretax Profit Margin |
Latest Bluebird Bio's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of Bluebird bio over the last few years. It is Bluebird Bio's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluebird Bio's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
Bluebird Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (39.80) | |
| Coefficient Of Variation | (110.55) | |
| Mean Deviation | 35.67 | |
| Median | (17.68) | |
| Standard Deviation | 43.99 | |
| Sample Variance | 1,935 | |
| Range | 152 | |
| R-Value | (0.53) | |
| Mean Square Error | 1,500 | |
| R-Squared | 0.28 | |
| Significance | 0.04 | |
| Slope | (5.21) | |
| Total Sum of Squares | 27,096 |
Bluebird Pretax Profit Margin History
About Bluebird Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bluebird Bio income statement, its balance sheet, and the statement of cash flows. Bluebird Bio investors use historical funamental indicators, such as Bluebird Bio's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although Bluebird Bio investors may use each financial statement separately, they are all related. The changes in Bluebird Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bluebird Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bluebird Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bluebird Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (85.19) | (80.93) |
Pair Trading with Bluebird Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluebird Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Bluebird Stock
| 0.65 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
Moving against Bluebird Stock
| 0.49 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Bluebird Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluebird Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluebird Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluebird bio to buy it.
The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluebird Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluebird bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bluebird Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bluebird Bio Correlation against competitors. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 0.214 | Quarterly Revenue Growth 173.535 | Return On Assets (0.15) | Return On Equity (0.48) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.